Trade GUTS stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Fractyl Health, Inc. (GUTS) is trading at US$4.03, down 8.62% today as of Oct 13, 15:53 EDT. The company has a market capitalisation of US$124.16M. Over the past 52 weeks, GUTS has traded between US$4.03 and US$29.34. On Syfe you can trade GUTS with $0 commission and add it to your watchlist.
| Previous close | US$4.41 |
|---|---|
| Market cap | US$124.16M |
| 52-week range | US$4.03 – US$29.34 |
| Volume | 133.06K |
| Exchange | US |
Fractyl Health, Inc.
Fractyl Health, Inc. is a metabolic therapeutics company. It develops medical device solutions for the treatment of metabolic diseases, which includes type 2 diabetes and obesity. The company was founded by Harith Rajagopalan and Jay D. Caplan on August 30, 2010 and is headquartered in Burlington, MA.
Year: 2024
Craig-Hallum Initiates Fractyl Health at Buy With $4 Price Target
Jul 1, 11:50 AM · MT Newswires
Fractyl Health Says One-Year Data Shows Revita Sustains Post-GLP-1 Weight Loss
Jun 4, 12:14 PM · MT Newswires
Fractyl Health, Inc. (GUTS) stock is trading at US$4.03, -8.62% from the previous close of US$4.41.
The market cap for Fractyl Health, Inc. (GUTS) stock is approximately US$124.16M.
The 52-week high for Fractyl Health, Inc. (GUTS) stock is US$29.34.
The 52-week low for Fractyl Health, Inc. (GUTS) stock is US$4.03.
Fractyl Health, Inc. (GUTS) does not currently pay a dividend.
Stay on top of GUTS
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
